SCHEMBL20124587

SCHEMBL20124587

CCc1ccccc1CCCN1CCCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.55
KDM4E B2RXH2 1/20 0.54
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
LTA4H P09960 1/20 0.51
SIGMAR1 Q99720 5/20 0.50
HRH3 Q9Y5N1 2/20 0.50
ALDH1A1 P00352 1/20 0.47
SLC6A3 Q01959 2/20 0.47
POLB P06746 1/20 0.47
SLC6A2 P23975 1/20 0.46
HTR2A P28223 1/20 0.46
DRD2 P14416 2/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C19 P33261 1/20 0.45
SLC6A4 P31645 1/20 0.45
DRD1 P21728 1/20 0.44
DRD4 P21917 1/20 0.44
DRD5 P21918 1/20 0.44
HRH1 P35367 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18926549 0.91 LTA4H (0.59) KDM4ELTA4HSIGMAR1HRH3ALDH1A1
SCHEMBL19043759 0.89 LTA4H (0.51) L3MBTL1KDM4EMEN1KMT2ALTA4H
SCHEMBL7983264 0.82 CYP2D6 (0.57) KMT2ALTA4HSIGMAR1HRH3ALDH1A1
SCHEMBL2088826 0.81 SIGMAR1 (0.45) L3MBTL1KDM4EMEN1KMT2ASIGMAR1
SCHEMBL11248323 0.81 L3MBTL1 (0.74) L3MBTL1KDM4EMEN1KMT2AALDH1A1
SCHEMBL791288 0.81 CYP2D6 (0.55) LTA4HSIGMAR1HRH3ALDH1A1DRD2
SCHEMBL19043541 0.79 HRH3 (0.80) KDM4ELTA4HSIGMAR1HRH3SLC6A3
SCHEMBL23644081 0.78 SIGMAR1 (0.45) L3MBTL1KDM4EMEN1KMT2ALTA4H
SCHEMBL7923985 0.78 HRH3 (0.82) MEN1KMT2ASIGMAR1HRH3ALDH1A1
SCHEMBL18934284 0.78 SIGMAR1 (0.51) L3MBTL1SIGMAR1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3318277-A1 INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE FOR THE TREATMENT OF MOTOR NEURON DISEASES Institut du Cerveau et de la Moelle Epiniere-ICM (FR) 2018-05-09 EP disclosed